UK markets closed

Hanall Biopharma Co., Ltd. (009420.KS)

KSE - KSE Delayed price. Currency in KRW
Add to watchlist
33,150.00+1,600.00 (+5.07%)
At close: 03:30PM KST
Currency in KRW
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts0035
Avg. Estimate00193.67345.4
Low estimate007591
High estimate00398752
Year ago EPS-2514469193.67
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts1366
Avg. EstimateN/A36.48M149.13M173.67M
Low estimate33.17M34.43M142M156M
High estimate33.17M37.7M160M198M
Year ago sales28.8MN/A134.91M149.13M
Sales growth (year/est)N/AN/A10.50%16.50%
Earnings history31/03/202330/06/202330/09/202331/12/2023
Est. EPS56.349.5316.0215.62
Actual EPS-251446-56.48
Difference-81.34134.47-10.02-72.1
Surprise %-144.40%1,411.00%-62.50%-461.60%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate00193.67345.4
7 days ago41.3927.21224405.6
30 days ago41.3927.21254435.8
60 days ago41.3927.21231.61402.64
90 days ago41.3927.21231.61402.64
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/A1
Up last 30 daysN/AN/AN/A2
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/A11
Growth estimates009420.KSIndustrySector(s)S&P 500
Current qtr.N/AN/AN/AN/A
Next qtr.N/AN/AN/AN/A
Current year180.70%N/AN/AN/A
Next year78.30%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)-29.66%N/AN/AN/A